- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05921981
Multisensory Stimulation Versus White Noise
Comparison of the Effectiveness of White Noise and Multisensory Stimulation in Retinopathy Examination
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aimed to compare the effectiveness of white noise and multisensory stimulation in retinopathy examination on premature infants. Retinopathy is a common eye disorder among premature infants that can lead to long-term visual impairments if left untreated. Therefore, finding effective interventions for retinopathy examinations is crucial for improving the overall visual health of these infants.
A randomized controlled experimental design was employed, with premature infants as the study participants. The infants were randomly assigned to three groups: the control group, the white noise group, and the multisensory stimulation group. The white noise group received auditory stimulation through the presentation of white noise, while the multisensory stimulation group received additional visual and tactile stimuli during the retinopathy examination.
Several outcome measures were used to evaluate the effectiveness of the interventions. These measures included physiological responses (e.g., heart rate, blood pressure), behavioral indicators (e.g., eye movement, crying), and overall examination success rate. The examination success rate was defined as the ability to complete the retinopathy examination without disturbances caused by infant distress or movement.
The study employed trained healthcare professionals who performed retinopathy examinations using standardized procedures. Data collection was conducted in a controlled environment to ensure consistency across three groups. Statistical analyses, such as ANOVA and chi-square tests, were employed to compare the outcomes between the three groups.
The findings of this study have the potential to contribute to the development of effective and well-tolerated retinopathy examination protocols for premature infants. By comparing the effects of white noise and multisensory stimulation, the study aims to provide insights into the most suitable intervention that can optimize the examination process, improve examination success rates, and minimize potential discomfort or distress experienced by infants.
It is anticipated that the results of this study will inform healthcare professionals and researchers about the benefits of auditory stimulation (white noise) and the additional advantages of multisensory stimulation during retinopathy examinations. Ultimately, this research aims to enhance the overall quality of care provided to premature infants, leading to improved visual outcomes and long-term well-being for this vulnerable population.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Antalya, Turkey
- Akdeniz University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Premature newborns with a gestational age of ≤ 32 weeks or newborns with a birth weight of < 1500 g, according to the records.
- Neonates undergoing a first-time eye exam to screen for retinopathy of prematurity.
- Newborns with their mother.
- Newborns who have not been fed in the last hour.
Exclusion Criteria:
- Newborns who need cardiopulmonary resuscitation (CPR) during the exam.
- Newborns experiencing apnea at the time of examination
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multisensorial Stimulation Group
The group to which multi-sensory stimulation will be applied during the retinopathy examination.
|
Multisensory stimulation in newborns involves the deliberate and simultaneous activation of multiple sensory modalities to provide sensory experiences that promote development and enhance learning.
Newborns are naturally inclined to explore and make sense of their environment through their senses, including touch, sight, sound, taste, and smell.
|
|
Active Comparator: White Noise Group
The group to which White Noise will be applied during the retinopathy examination.
|
White Noise
|
|
No Intervention: Control Group
The group that will receive routine care during the retinopathy examination
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal Pain
Time Frame: first 30 minutes during procedure
|
The Premature Infant Pain Profile (PIPP) is a validated and widely used tool designed to assess pain in preterm infants.
It takes into account physiological and behavioral indicators that are indicative of pain in this population.
The PIPP scale includes the evaluation of facial expressions, gestational age, heart rate, oxygen saturation, and behavioral state to assess pain levels.
Accordingly, the highest is 21 points and the lowest is 0 points.
If the Premature Baby Pain Profile is between 0-6 points, the pain is considered mild, 7-12 points moderate, 13-21 points severe.
|
first 30 minutes during procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Halil İbrahim HI Taşdemir, PhD, Burdur Mehmet Akif Ersoy University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAKU23-368
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinopathy
-
Washington University School of MedicineCompletedCentral Serous Retinopathy (CSR)United States
-
The Cleveland ClinicWithdrawn
-
Greater Houston Retina ResearchGenentech, Inc.Completed
-
Amy C Schefler, MDRegeneron PharmaceuticalsUnknownRadiation RetinopathyUnited States
-
The New York Eye Cancer CenterGenentech, Inc.CompletedRadiation RetinopathyUnited States
-
The Eye Center and The Eye Foundation for Research...King Khalid University HospitalCompletedHydroxychloroquine Toxic RetinopathySaudi Arabia
-
Dr. S.S. Michel ClinicCompletedSickle Cell Retinopathy
-
King's College Hospital NHS TrustLUPUS UK; King's College Hospital CharityRecruitingHydroxychloroquine RetinopathyUnited Kingdom
-
University of CologneCompleted
-
Ahalia Foundation Eye HospitalCompletedProliferative Diabetic Retinopathy | Retinal Detachment | Proliferative Vitreo-RetinopathyIndia
Clinical Trials on Multisensorial Stimulation
-
Akdeniz UniversityBurdur Mehmet Akif Ersoy UniversityCompleted
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
National Council of Scientific and Technical Research...Completed
-
National Cheng-Kung University HospitalRecruiting
-
Clinique Beau SoleilNot yet recruiting
-
University of Sao Paulo General HospitalActive, not recruitingTraumatic Brain Injury | Post-Concussion SymptomsBrazil
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterCompletedHealthyKorea, Republic of
-
Northwestern UniversityUniversity of Missouri-Columbia; University of Miami; National Institute on Deafness...Enrolling by invitation
-
Charite University, Berlin, GermanyCompletedOlder Adults (50-90 Years)Germany